Application no. and date | 06740898.9 (espacenet) (Federated) (European Patent Register), 20060411 | Patent/reg. no. and date | DK/EP 1868581, 20120314 | Publication date | 20071226 | Priority no. and date | US 670207 P, 20050411 | EP pub. no. and date |
EP 1868581 20071226 | Effective date | | Applicant/owner | AbbVie Inc., 1 North Waukegan Road North Chicago, IL 60064, US | Applicant ref. no. | P009542EPDK1 | Inventor | WU, Huailiang, 8094 Rfd Breckenridge Dr
Long Grove, IL 60047, US, ZHANG, Geoff, 1014 Dawes
Libertyville, IL 60048, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/47 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 31/04 (2006.01) | Title | Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler | Int. application no. | US2006013651 | Int. publication no. | WO2006110815 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|